Evaluation of Ornidazole Tablets Bioequivalence in Chinese Healthy Participants Under Fasted and Fed Conditions Using Pharmacokinetic Parameters

ConclusionThe bioequivalence and tolerability of ornidazole tablet reference and test formulations were evaluated among healthy Chinese participants under both fasting and fed conditions. The results indicated that both formulations were bioequivalent and generally well tolerated; besides, the interaction between food and drug may affect drug pharmacokinetics.Trial RegistrationCTR20212873, registered on 15 November 2021; ChiCTR2300069098, registered on 7 March 2023.
Source: Drugs in R&D - Category: Drugs & Pharmacology Source Type: research